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The patient was an 88-year-old male. He was referred to the Department of Internal Medicine
because of total body itching and jaundice in July 2011. The serum bilirubin level was elevated, and the
serum CA19-9 level was also elevated to 266. 6 U/ml. Computed tomography (CT) and endoscopic
retrograde cholangiopancreatography (ERCP) revealed a solid tumor between the hepatic hilus and common
bile duct, and choler cytodiagnosis was class V ; adenocarcinoma. The patient was diagnosed with hilar
cholangiocarcinoma and received conservative treatment with endoscopic nasobiliary drainage (ENBD) due
to his advanced age. The patient was then referred to our department because CT revealed right
hydronephrosis and thickening of the right side of the bladder wall, which had not been detected on
admission in October 2011. Cystoscopy revealed a broad-based edematous tumor on the right side of the
bladder. Transurethral resection of the bladder tumor (TURBT) was performed. The histological
diagnosis was moderately differentiated tubular adenocarcinoma. Immunohistostaining using CA19-9 was
performed, and cancer cells were positive. The ﬁnal histology led to a diagnosis of metastasis of
cholangiocarcinoma to the bladder. The patient died of liver failure in March 2012.
(Hinyokika Kiyo 64 : 165-168, 2018 DOI : 10.14989/ActaUrolJap_64_4_165)












患 者 : 88歳，男性
既往歴 : 特記すべきことなし
主 訴 : 右水腎症と膀胱壁肥厚の精査









の CT で入院時に認めなかった右水腎症（Fig. 2a）と
膀胱の右側壁の肥厚（Fig. 2b）が出現し同月に当科へ
紹介された．
現 症 : 血圧 119/46 mmHg，体温 37.9°C，脈拍95
回/分．腹部は平坦，腫瘤は触れず．
内科入院時検査所見（2011年 7月）
血液一般 : RBC 350万 / μ l，Hb 11. 6 g/dl，WBC
5,800/μl，Plt 18.0万/μl
血液生化学 : Total Bil 15.8 mg/dl，direct Bil 10.8
mg/dl，AMY 96 U/l，GOT 95 U/l，GPT 82 U/l，γ -
GTP 823 U/l．腎機能，電解質正常．CRP 1.17 mg/dl
PT-活性96.5％，APTT 33.2秒
CA19-9 266.6 U/ml（正常 37.0 以下）
CEA 2.6 ng/ml（正常 5.0 以下）
検 尿 : 褐色，PH 6. 0，糖（−），蛋白（30 mg/
dl），ケトン（−），ウロビリノーゲン（＋），ビリル
ビン（3＋），潜血（−）





Fig. 1. a) CT revealed a solid tumor between the
hepatic hilus and common bile duct. The
arrows show a solid tumor. b) ERCP
revealed a ﬁlling defect from the hepatic
portal region to the upper part of the bile





Fig. 2. a) CT revealed right hydronephrosis. The
upper arrow shows the tube stent, and the
lower arrow shows the right hydronephrosis.
b) CT revealed thickening of the right side of
the bladder.
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Fig. 3. Cystoscopy revealed a broad-based edema-
tous bladder tumor.












の2011年 9 月には 89.8 U/ml まで一旦下降したが
2012年 1月には 401.8 U/ml まで上昇した．さらに同










Fig. 4. a) Histopathological ﬁndings revealed a
moderately differentiated tubular adenocar-
cinoma (H-E staining, objective lens, ×10).
b) Cancer cells were positive on immunohis-
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